Gangloff Scott A.

CIK 00016632532 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001663253

Recent Transactions

16 trades

Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−17,784→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−73,700→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−204,616→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−5,088→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−21,263→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-08-15$19.62/sh+2,600→ 26,351 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock option (Right to Buy)
2025-08-15−2,600→ 17,784 total
Award
Akero Therapeutics, Inc.
Common Stock
2025-06-30$23.87/sh+299→ 23,751 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-18$54.84/sh−848→ 23,452 total
Award
Akero Therapeutics, Inc.
Common Stock
2024-12-16+24,300→ 24,300 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2024-12-16+73,700→ 73,700 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2024-04-29+225,000→ 225,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2016-12-21+40,000→ 118,573 total
Sale
Outlook Therapeutics, Inc.$OTLK
Common Stock
2016-11-11$3.75/sh−37,369→ 78,573 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2016-11-09+115,942→ 115,942 total
Conversion
Outlook Therapeutics, Inc.$OTLK
Restricted Stock Units
2016-11-09−115,942→ 0 total

Companies

Recent Filings

Address

C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov